Financials

  • Market Capitalization 9.35 B
  • Employee 273
  • Founded 2015
  • CEO N/A
  • Website www.kymeratx.com
  • Headquarter Delaware, United States
  • FIGI BBG00SDHC8D1
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-21.09
市销率
167.66

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
890
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
79.78 USD+1.31%+5.02%+2.43%+101.24%10.15 B USD
907
KRYS
Krystal Biotech, Inc. - Common Stock
331.61 USD+1.32%+2.42%-5.46%+77.21%9.82 B USD
933
PTGX
Protagonist Therapeutics, Inc. - Common Stock
143.73 USD+2.73%+2.04%-4.13%+91.31%9.30 B USD
961
ARWR
Arrowhead Pharmaceuticals, Inc. - Common Stock
62.75 USD+3.31%-3.10%-24.13%+60.49%8.86 B USD

新闻